Chronic Kidney Disease: Detection and Evaluation
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Chronic kidney disease (CKD) is a prevalent disease that continues to affect more than one-tenth of the American population. Early detection is essential to slow the natural progression of CKD. This can be accomplished by urine and blood screening tests, which are analyzed for creatinine, urine albumin, and urine protein. Screening is often indicated for individuals with known comorbidities such as cardiovascular disease, mineral and bone disorders, and diabetes. Asymptomatic patients with early renal disease can make detection problematic, requiring clinicians to recognize risk factors that may warrant further testing. When symptoms do appear, the renal manifestations are often broad, including changes in kidney size, electrolyte abnormalities, and proteinuria. Changes in biomarkers may be evaluated in the early stages of CKD before significant kidney damage. The current, most accurate determination of renal function is the estimated glomerular filtration rate (GFR), which must be less than 60 mL/min to prompt further testing for CKD. Novel biomarkers may allow for earlier diagnosis of CKD as they can be detected at lower levels than standard biomarkers. Biomarkers such as homocysteine, cystatin C, and kidney injury molecule-1 are predicted to become more prevalent in a clinical setting. The current gold standard for diagnosis of CKD is a renal biopsy, but MRI is a less invasive alternative. Proper staging of CKD allows for appropriate evaluation and treatment of the patient. The early stages of CKD should be treated to limit complications and to prolong the life and health of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B., & Smith, D. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.659 · Cited by 1,684
The global burden of kidney disease and the sustainable development goals
Luyckx, V. A., Tonelli, M., & Stanifer, J. W. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.206441 · Cited by 926
Raghupathi, W., & Raghupathi, V. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15030431 · Cited by 531
Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey
Jones, C. A., Francis, M. E., Eberhardt, M. S., Chavers, B., Coresh, J., Engelgau, M., Kusek, J. W., Byrd-Holt, D., Narayan, K. M. V., Herman, W. H., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31388 · Cited by 444
(2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.10.001 · Cited by 363
Chronic kidney disease and cardiovascular disease in the Medicare population
Collins, A. J., Li, S., Gilbertson, D. T., Liu, J., Chen, S.-C., & Herzog, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s87.5.x · Cited by 346
Drug-induced nephrotoxicity: concluded
(1984) · Reactions · doi:10.1007/bf03273412 · Cited by 339
Abramson, J. L., Jurkovitz, C. T., Vaccarino, V., Weintraub, W. S., & Mcclellan, W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00109.x · Cited by 336
NSAID Use and Progression of Chronic Kidney Disease
Gooch, K., Culleton, B. F., Manns, B. J., Zhang, J., Alfonso, H., Tonelli, M., Frank, C., Klarenbach, S., & Hemmelgarn, B. R. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.015 · Cited by 333
Testing for chronic kidney disease: a position statement from the National Kidney Foundation
Vassalotti, J. A., Stevens, L. A., & Levey, A. S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.013 · Cited by 331
Ketteler, M., Block, G. A., Evenepoel, P., Fukagawa, M., Herzog, C. A., McCann, L., Moe, S. M., Shroff, R., Tonelli, M. A., Toussaint, N. D., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2640 · Cited by 318
Patient Awareness of Chronic Kidney Disease: Trends and Predictors
Plantinga, L. C., Boulware, L. E., Coresh, J., Stevens, L. A., Miller, E. R., Saran, R., Messer, K. L., Levey, A. S., & Powe, N. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2268 · Cited by 317
The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease
Wang, V., Vilme, H., Maciejewski, M. L., & Boulware, L. E. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.008 · Cited by 316
Drug dosing adjustments in patients with chronic kidney disease.
Munar, M. Y., & Singh, H. (2007) · PubMed · Cited by 307
Vassalotti, J. A., Centor, R., Turner, B. J., Greer, R. C., Choi, M., & Sequist, T. D. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.025 · Cited by 291
Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
Rysz, J., Gluba-Brzózka, A., Franczyk, B., Jabłonowski, Z., & Ciałkowska-Rysz, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081702 · Cited by 278
Chronic Kidney Disease Progression
Eddy, A. A., & Neilson, E. G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070704 · Cited by 200
Bowe, B., Xie, Y., Li, T., Mokdad, A. H., Xian, H., Yan, Y., Maddukuri, G., & Al-Aly, Z. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.4412 · Cited by 168
Fan, L., Inker, L. A., Rossert, J., Froissart, M., Rossing, P., Mauer, M., & Levey, A. S. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft509 · Cited by 101
Tsai, C.-W., Grams, M. E., Inker, L. A., Coresh, J., & Selvin, E. (2014) · Diabetes Care · doi:10.2337/dc13-1910 · Cited by 67
Over-the-Counter Analgesic Use
Broe, M. E. D., & Elseviers, M. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101097 · Cited by 64
Identifying Important Attributes for Early Detection of Chronic Kidney Disease
Anandanadarajah, N., & Thiruvaran, T. (2017) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2017.2787480 · Cited by 61
Patterns of progression of chronic kidney disease at later stages
Caravaca‐Fontán, F., Azevedo, L. M. O., Luna, E., & Caravaca, F. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx083 · Cited by 58
Screening for Chronic Kidney Disease: Unresolved Issues
McClellan, W. M., Ramirez, S. P. B., & Jurkovitz, C. T. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070144.86024.04 · Cited by 58
Vest, B. M., York, T. R., Sand, J., Fox, C. H., & Kahn, L. (2015) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2015.05.150070 · Cited by 56
Cernaro, V., Coppolino, G., Visconti, L., Rivoli, L., Lacquaniti, A., Santoro, D., Buemi, A., Loddo, S., & Buemi, M. (2018) · Medicinal Research Reviews · doi:10.1002/med.21527 · Cited by 55
A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury
Watson, D., Yang, J., Sarwal, R. D., Sigdel, T. K., Liberto, J. M., Damm, I., Louie, V., Sigdel, S., Livingstone, D. M., Soh, K. K., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040499 · Cited by 54
Lobato, G., Lobato, M. R., Thomé, F. S., & Veronese, F. V. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176106 · Cited by 53
Cohen, E., Margalit, I., Shochat, T., Goldberg, E., & Krause, I. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00618-x · Cited by 42
CKD for Primary Care Practitioners: Can We Cut to the Chase Without Too Many Shortcuts?
Thavarajah, S., Knicely, D. H., & Choi, M. J. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.02.043 · Cited by 38
Microalbuminuria, Blood Pressure Load, and Systemic Vascular Permeability in Primary Hypertension
Viazzi, F. C., Leoncini, G., Ratto, E., VACCARO, V., Tomolillo, C., Falqui, V., PARODI, A., Conti, N. E., Deferrari, G., & Pontremoli, R. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.012 · Cited by 36
In Vivo Detection of Chronic Kidney Disease Using Tissue Deformation Fields From Dynamic MR Imaging
Hodneland, E., Keilegavlen, E., Hanson, E., Andersen, E., Monssen, J. A., Rørvik, J. T., Leh, S. M., Marti, H., Lundervold, A., Svarstad, E., et al. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2018.2879362 · Cited by 30
Reducing CKD Risks Among Vulnerable Populations in Primary Care
Greer, R. C., & Boulware, L. E. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.06.003 · Cited by 28
Alsaleh, M. A., Videloup, L., Lobbedez, T., Lebreuilly, J., Morello, R., & Lecouf, A. T. (2019) · Kidney Diseases · doi:10.1159/000497352 · Cited by 21
Risk Factors and Screening for Chronic Kidney Disease
Vassalotti, J. A., Fox, C. H., & Becker, B. N. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.03.003 · Cited by 20
Regan, M. E. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12505 · Cited by 17
Barr, E. L., Reutens, A. T., Magliano, D. J., Wolfe, R. S., Lu, Z. X., Sikaris, K. A., Tanamas, S. K., Atkins, R. C., Chadban, S. J., Shaw, J. E., et al. (2016) · Nephrology · doi:10.1111/nep.12759 · Cited by 13
Mwengi, E. M., Nyamu, D. G., Njogu, P., & Karimi, P. N. (2019) · Hospital Practice · doi:10.1080/21548331.2019.1630286 · Cited by 5
Metadata
- Authors
- Raena M. Pettitt, D., Alonna P. Brumbaugh, O.-I., Michaela F. Gartman, O.-I., & Alyssa M. Jackson, O.-I.
- Venue
- Osteopathic Family Physician
- Published
- 2020-01-03
- Volume
- 12
- Issue
- 1
- Pages
- 14-19
- ISSN
- 1877-573X (ISSN-L)
- OpenAlex
- W2997463042
- Cited by
- 192
- References
- 43
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.